Skip to main content

Moderna COVID-19 vaccine was linked to myocarditis or myopericarditis at 28 d (4.2 events/100 000 persons).

Publication ,  Journal Article
Krychtiuk, KA; Newby, LK
Published in: Ann Intern Med
May 2022

Husby A, Hansen JV, Fosbøl E, et al. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study. BMJ. 2021;375:e068665. 34916207.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Intern Med

DOI

EISSN

1539-3704

Publication Date

May 2022

Volume

175

Issue

5

Start / End Page

JC58

Location

United States

Related Subject Headings

  • Vaccination
  • SARS-CoV-2
  • Myocarditis
  • Humans
  • General & Internal Medicine
  • Cohort Studies
  • COVID-19
  • 3202 Clinical sciences
  • 2019-nCoV Vaccine mRNA-1273
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Krychtiuk, K. A., & Newby, L. K. (2022). Moderna COVID-19 vaccine was linked to myocarditis or myopericarditis at 28 d (4.2 events/100 000 persons). Ann Intern Med, 175(5), JC58. https://doi.org/10.7326/J22-0021
Krychtiuk, Konstantin A., and L Kristin Newby. “Moderna COVID-19 vaccine was linked to myocarditis or myopericarditis at 28 d (4.2 events/100 000 persons).Ann Intern Med 175, no. 5 (May 2022): JC58. https://doi.org/10.7326/J22-0021.
Krychtiuk, Konstantin A., and L. Kristin Newby. “Moderna COVID-19 vaccine was linked to myocarditis or myopericarditis at 28 d (4.2 events/100 000 persons).Ann Intern Med, vol. 175, no. 5, May 2022, p. JC58. Pubmed, doi:10.7326/J22-0021.

Published In

Ann Intern Med

DOI

EISSN

1539-3704

Publication Date

May 2022

Volume

175

Issue

5

Start / End Page

JC58

Location

United States

Related Subject Headings

  • Vaccination
  • SARS-CoV-2
  • Myocarditis
  • Humans
  • General & Internal Medicine
  • Cohort Studies
  • COVID-19
  • 3202 Clinical sciences
  • 2019-nCoV Vaccine mRNA-1273
  • 11 Medical and Health Sciences